Cardiol Therapeutics Inc.CRDL
Price (close)
$1.71
Market cap
$171.4M
P/E
—
Revenue (FY)
—
Net income
-$33.8M
Dividend yield
—
1-year total return
58.3%
Net margin
—
Revenue growth
—
Debt / equity
—
What Cardiol Therapeutics Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | — | $78,760 | — | — | — | — |
| Net income | -$20.6M | -$31.6M | -$30.9M | -$28.1M | -$36.7M | -$33.8M |
| Free cash flow | -$9.2M | -$23.6M | -$27.3M | -$25.2M | -$25.1M | -$23.9M |
More on CRDL.
- Cardiol Therapeutics Inc. summary
- Cardiol Therapeutics Inc. financial statements
- Cardiol Therapeutics Inc. key metrics
- Cardiol Therapeutics Inc. health scores and style box
- Cardiol Therapeutics Inc. earnings
- Cardiol Therapeutics Inc. dividends
- Cardiol Therapeutics Inc. valuation
- Cardiol Therapeutics Inc. ownership and insiders
- Cardiol Therapeutics Inc. peers
Figures from Cardiol Therapeutics Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.